Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jarle Aarstad has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Mortality involving and not involving COVID-19 among vaccinated vs. unvaccinated in England between Apr 21 and May 23

    by Jarle Aarstad

    Background Comparing non-randomized groups, such as COVID-19 vaccinated and unvaccinated, even in the presence of seemingly relevant control variables, is challenging, but in this study, using English data, I show an achievable approach. Methods First, I estimated age-standardized all-cause mortality among vaccinated and unvaccinated ten years and older, covering 26 months from Apr 21 to May 23. Then, I estimated mortality not involving COVID-19, and finally, I contrasted the calculations. Results First, I found that all-cause mortality among unvaccinated was higher than among vaccinated. But, as the pattern was similar concerning mortality not involving COVID-19, the discrepancy can be attributed mainly to unvaccinated having inferior health at the outset. There were nonetheless indications of significant protection for vaccinated between July 21 and Jan 22. In the absence of control variables as a means to compare non-randomized groups, I reached that conclusion by contrasting all-cause mortality with mortality not involving COVID-19. However, while mortality not involving COVID-19 decreased among unvaccinated compared to the first observation month, it remained high among vaccinated, indicating a relative increase. Conclusions An interpretation is that vaccination, despite a potential temporary protection, has increased mortality. Strengthening the interpretation was relatively high mortality among vaccinated not involving COVID-19 counterintuitively following periods of excess mortality. Further strengthening the interpretation was the relatively high mortality not involving COVID-19 among vaccinated, corresponding with excess mortality during much of the same period. Future research should include data over a longer period than those available for this study. Also, future research should examine different age groups, vaccination types, and the number of doses given.


  • Open Access

    Why COVID-19 vaccination cannot be ruled out as an explanation for all-cause excess mortality in the pandemic’s aftermath: A population-level study of over 3,000 US counties with over 320 million people

    by Jarle Aarstad

    Background Research has shown consistent excess all-cause mortality since the COVID-19 pandemic, but without a clear explanation. In parallel, research has shown side effects from COVID-19 vaccination and increased deaths. Therefore, one cannot rule out COVID-19 vaccination as an explanation for the excess mortality. Methods US county-level data were used to model 2022 and 2023 all-cause excess mortality as dependent variables and per capita COVID-19 vaccine uptake at the end of 2021 and 2022 as independent variables. I included lagged dependent variables as controls. The data include over 3,000 US counties. Results A one-unit increase in per-capita vaccination uptake was significantly associated with a .042 (95% CI: .030–.055) increase in 2022 all-cause excess mortality, and significantly associated with a.030 (95% CI: .024–.036) increase in 2023. Conclusions COVID-19 vaccine uptake was significantly positively associated with all-cause excess mortality. Given the time asymmetry between vaccine uptake and all-cause excess mortality, the inclusion of lagged dependent variables as controls, and the large number of observations, the study has strong internal validity.


  • Open Access

    Why COVID-19 Vaccination Cannot be Ruled out as an Explanation for All-Cause Excess Mortality in the Pandemic’s Aftermath: A Population-Level Study of over 3000 US Counties with over 320 Million People

    by Jarle Aarstad

    Background/Objectives: Research has shown consistent excess all-cause mortality since the COVID-19 pandemic, but without a clear explanation. In parallel, research has shown side effects from COVID-19 vaccination and increased deaths. Therefore, one cannot rule out COVID-19 vaccination as an explanation for the excess mortality. Methods: US county-level data were used to model 2022 and 2023 all-cause excess mortality as dependent variables and per capita COVID-19 vaccine uptake by the end of 2021 and 2022 as independent variables. I included lagged dependent variables as controls. The data includes over 3,000 US counties with over 320 million people. Re-sults: A one-unit increase in per-capita vaccination uptake was significantly associat-ed with a .033 (95% CI: .021–.045) increase in 2022 all-cause excess mortality, and sig-nificantly associated with a .027 (95% CI: .021–.033) increase in 2023. Average vaccine uptake was associated with 4.39% (95% CI: 2.78–6.00) higher mortality in 2022 com-pared to assuming zero vaccine uptake, and 137,900 (95% CI: 89,537–186,262) addi-tional deaths. For 2023, there were 5.16% (95% CI: 4.01–6.31) higher mortality and 151,543 (95% CI: 119,397–183,690) additional deaths. Conclusions: COVID-19 vaccine uptake was significantly positively associated with all-cause excess mortality. Given the time asymmetry between vaccine uptake and all-cause excess mortality, the inclu-sion of lagged dependent variables as controls, the large number of observations, and the strongly significant effects, the study has strong internal validity. I.e., vaccine up-take has genuinely caused increased mortality. Also, the study has strong external va-lidity since it covers almost every US county.

  • Open Access

    Mortality involving and not involving COVID-19 among vaccinated vs. unvaccinated in England between Apr 21 and May 23

    by Jarle Aarstad

    Background Comparing non-randomized groups, such as COVID-19 vaccinated and unvaccinated, even in the presence of seemingly relevant control variables, is challenging, but in this study, using English data, I show an achievable approach. Methods First, I estimated age-standardized all-cause mortality among vaccinated and unvaccinated ten years and older, covering 26 months from Apr 21 to May 23. Then, I estimated mortality not involving COVID-19, and finally, I contrasted the calculations. Results First, I found that all-cause mortality among unvaccinated was higher than among vaccinated. But, as the pattern was similar concerning mortality not involving COVID-19, the discrepancy can be attributed mainly to unvaccinated having inferior health at the outset. There were nonetheless indications of significant protection for vaccinated between July 21 and Jan 22. In the absence of control variables as a means to compare non-randomized groups, I reached that conclusion by contrasting all-cause mortality with mortality not involving COVID-19. However, while mortality not involving COVID-19 decreased among unvaccinated compared to the first observation month, it remained high among vaccinated, indicating a relative increase. Conclusions An interpretation is that vaccination, despite a potential temporary protection, has increased mortality. Strengthening the interpretation was relatively high mortality among vaccinated not involving COVID-19 counterintuitively following periods of excess mortality. Further strengthening the interpretation was the relatively high mortality not involving COVID-19 among vaccinated, corresponding with excess mortality during much of the same period. Future research should include data over a longer period than those available for this study. Also, future research should examine different age groups, vaccination types, and the number of doses given.

  • Open Access

    COVID-19 Vaccination and National-Level Long-Term Mortality

    by Jarle Aarstad

    Background: Previous research has indicated that COVID-19 vaccination can reduce mortality, but diminishing protection and side effects have also been demonstrated. We can, therefore, not rule out that countries’ vaccination rates have affected mortality differently over time. That is, as vaccines may reduce national mortality temporarily, we know less about long-term effects. Methods: To study the research question, I used Our World in Data from 39 high-income countries and analysed them from early 2021 to the end of 2023. My motive for analysing those countries was relative homogeneity, presumably relatively high data quality, and, most importantly, they provided relatively consistent data during the study period. Analyses were weighted for population size. Results: From the last half of 2021 to February-March 2022, all-cause mortality was relatively low in countries with relatively high vaccination rates, which indicates temporal protection. However, a similar association concerning mortality excluding COVID-19 counters that explanation but not ruled out as it was less marked than between vaccination and all-cause excess mortality. From the beginning of March 2022, the vaccine rollout had stabilized, and since then, to the end of 2023, the mortality was consistently higher the higher the countries’ vaccination rate. The association was robust when controlling for alternative explanations. Conclusions: COVID-19 vaccination may induce limited short-term protection against mortality, but the long-term effect appears detrimental. As the analyses controlled for alternative explanations concerning the vaccine’s detrimental long-term mortality effect, ecological fallacy is not a major threat to the study’s internal validity.

  • Open Access

    Mortality involving and not involving COVID-19 among vaccinated vs. unvaccinated in England between Apr 21 and May 23

    by Jarle Aarstad

    Background Comparing non-randomized groups, such as COVID-19 vaccinated and unvaccinated, even in the presence of seemingly relevant control variables, is challenging, but in this study, using English data, I show an achievable approach. Methods First, I estimated age-standardized all-cause mortality among vaccinated and unvaccinated ten years and older, covering 26 months from Apr 21 to May 23. Then, I estimated mortality not involving COVID-19, and finally, I differentiated the calculations. Results First, I found that all-cause mortality among unvaccinated was higher than among vaccinated. But, as the pattern was similar concerning mortality not involving COVID-19, the discrepancy is attributed mainly to unvaccinated having inferior health at the outset. There was nonetheless significant protection for vaccinated between July 21 and Jan 22. Absent of control variables as a means to compare non-randomized groups, I reached that finding by differentiating all-cause mortality from mortality not involving COVID-19. However, while mortality not involving COVID-19 decreased among unvaccinated compared to the first observation month, it was high among vaccinated, i.e., a relative increase in mortality among vaccinated. Conclusions An interpretation is that vaccination, despite temporary protection, increased mortality. Strengthening the interpretation was relatively high mortality among vaccinated not involving COVID-19 counterintuitively following periods of excess mortality. Further strengthening the interpretation was relatively high mortality not involving COVID-19 among vaccinated, corresponding with excess mortality during much of the same period. An implication of the study, which particularly has relevance for future pandemics, is that vaccinated may have a limited time window of protection and can even be exposed to detrimental health consequences. The pattern should be followed up over an extended period in future research. Also, future research should examine different age groups, vaccination types, and the number of doses given.

  • Open Access

    The temporal protection and declining health of the COVID-19 vaccinated in England: A 26-month comparison of the mortality involving and not involving COVID-19 among vaccinated vs. unvaccinated

    by Jarle Aarstad

    Background Comparing non-randomized groups, such as COVID-19 vaccinated and unvaccinated, even in the presence of seemingly relevant control variables, is challenging, but in this study, using English data, I show an achievable approach. Methods First, I estimated age-standardized all-cause mortality among COVID-19 vaccinated and unvaccinated ten years and older, covering a 26-month period from Apr 21 to May 23. Then, I estimated mortality not involving COVID-19, and finally, I differentiated the calculations. Results First, I found that all-cause mortality among COVID-19 unvaccinated was higher than among vaccinated. But as the pattern was similar concerning mortality not involving COVID-19, the discrepancy is attributed mainly to unvaccinated having inferior health at the outset. There was nonetheless significant protection for vaccinated between July 21 and Jan 22. Absent of control variables as a means to compare non-randomized groups, I reached that finding by differentiating all-cause mortality from mortality not involving COVID-19. However, while mortality not involving COVID-19 decreased among unvaccinated compared to the first observation month, it was high among vaccinated, i.e., a relative increase in mortality among vaccinated. Conclusions An interpretation is that vaccination, despite temporary protection, increased mortality. Strengthening the interpretation was relatively high mortality among vaccinated not involving COVID-19 counterintuitively following periods of excess mortality. Further strengthening the interpretation was relatively high mortality not involving COVID-19 among vaccinated corresponding with the excess mortality during the same period.

  • Open Access

    The Temporal Protection and Declining Health of the COVID-19 Vaccinated in England: A 26-Month Comparison of the Mortality Involving and Not Involving COVID-19 Among Vaccinated vs. Unvaccinated

    by Jarle Aarstad

    In England, from Apr 21 to May 23, all-cause mortality among COVID-19 unvaccinated ten years and older was higher than among vaccinated. But as the pattern was similar concerning mortality not involving COVID-19, the discrepancy is attributed mainly to unvaccinated having inferior health at the outset. There was nonetheless significant protection for vaccinated between July 21 and Jan 22. Absent of control variables as a means to compare non-randomized groups, I reached that conclusion by differentiating all-cause mortality from mortality not involving COVID-19. However, while mortality not involving COVID-19 decreased among unvaccinated compared to the first observation month, it was high among vaccinated, i.e., a relative increase in mortality among vaccinated. An interpretation is that vaccination, despite temporary protection, increased mortality. Strengthening the interpretation was relatively high mortality among vaccinated not involving COVID-19 counterintuitively following periods of excess mortality. Further strengthening the interpretation was relatively high mortality not involving COVID-19 among vaccinated corresponding with the excess mortality during the same period.

  • Open Access

    Governmental Revenue Compensation during COVID-19: Did Firm Resources and Institutional Factors Explain Who Received It?

    by Jarle Aarstad, Stig-Erik Jakobsen, Arnt Fløysand, Olav Andreas Kvitastein

    During COVID-19, the Norwegian Government provided compensation to amend firms’ decreased revenues, yet it should be neutral and tailored to losses only. However, firm resources or institutional factors may have influenced the compensation, which we study here. Survey data showed a high probability of compensation among large firms, although they were not hit particularly hard by COVID-19. Also, compensation was prevalent for firms in the hospitality, tourism, and culture industry, and a likely explanation is that they were hit hard. However, their probability of compensation was prevalent compared to firms in other industries, regardless of revenue losses. We assume that large firms’ compensation was due to their resources to apply for funding successfully, while institutional factors explained the compensation for firms in the hospitality, tourism, and culture industry.